4K. ?kesson,K.-H. W. Lau,D. J. Baylink. Rationale for Active Vitamin D Analog Therapy in Senile Osteoporosis[J] 1997,Calcified Tissue International(1):100～105
5L. M. Salamone,R. Ferrell,D. M. Black,L. Palermo,R. S. Epstein,N. Petro,N. Steadman,L. H. Kuller,J. A. Cauley. The association between vitamin D receptor gene polymorphisms and bone mineral density at the spine, hip and whole-body in premenopausal women[J] 1996,Osteoporosis International(1):63～68
4Schairer C, Lubin J, Troisi R, et al. Menopausal estrogen and estrogen-progestin replacement therapy and breast cancer risk[J]. JAMA,2000;283(4) :485 -491.
5Ceresini G, Morganti S, Rebecchi I,et al. A one-year follow-up on the effects of raloxifene on thyroid function in postmenopausal women[J].Menopause,2004;11(2) :176 -179.
6Cano A,Hermenegildo C. Modulation of the ocstrogen receptor: A process with distinct susceptible steps [J]. Hum Reprod Update,2000;6(3) :207 -211.
7Schairer C,Lubin J,Troisi R,et al.Menopausal estrogen and estrogen-progestin replacement therapy and breast cancer risk[J].JAMA,2000,283(4):485-491.
8Kobayashi K,Takahashi N,jimi E,et al.Tumor necrosis factor alpha stimulates osteoblast differentiation by a mechanism independent of the ODF/RANKL-RANK interaction[J].J Exped Med,2000,191;275.
10Hofbauer LC,Lacey DL,Dunstan CR,et al.Interleukin-1β and tumor necrosis factor-α,but not IL-6 stimulate osteoprotegerin ligand gene expressiom in human osteoblastic cells[J].Bone,1999,25:255.
